View Clinical Trial (Medical Research Study)
Infantile Hemangioma Tumor Size and C/T Polymorphism Within CTCF Binding Site Six
| City: |
|
New HAven |
| State: |
|
Connecticut |
| Zip Code: |
|
06519 |
| Conditions: |
|
Hemangioma |
| Purpose: |
|
The purpose of this study is to evaluate the genotype of CTCF, a proven transcription
factor, in patients with infantile hemangiomas and to monitor tumor growth. The
investigators aim to determine whether or not the CTCF genotype might serve as an early and
reliable predictor of tumor growth.
|
| Study Summary: |
|
This study seeks to examine a potential relationship between CTCF genotype and hemangioma
size and growth rate. In addition to the initial visit, patients will return to our clinic
for evaluation at two weeks, one month, two months, six months, and one year. At each
visit, patients' hemangiomas will be measured and photographed. At one point over the
course of evaluation, a blood sample will be taken from each patient for evaluation of C/T
polymorphism at CTCF binding site six.
|
| Criteria: |
|
Inclusion Criteria:
- Hemangioma must appear within one month prior to enrollment
Exclusion Criteria:
- Hemangioma appeared before one month prior to enrollment
|
| NCT ID: |
|
NCT00974129 |
| Primary Contact: |
|
Principal Investigator
Deepak Narayan, MD
Yale University
Alexandra C Sowa, BA, MA
Phone: 443-386-3808
Email: Alexandra.Sowa@yale.edu
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
New HAven, Connecticut 06519
United States
Alexandra Sowa, BA, MA
Phone: 443-386-3808
Email: Alexandra.Sowa@yale.edu
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 18, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|